Mark Swendsen

Mark Swendsen has a diverse work experience spanning multiple industries. Their most recent role is as the Chief Revenue Officer (CRO) at Form Bio, a company focused on scientific discovery through synthetic biology innovation. Mark also served as an Advisor and CRO at Colossal Biosciences, a company co-founded by renowned geneticist George Church.

Prior to their current roles, Mark Swendsen held various leadership positions, including CRO at DNAnexus, a company accelerating genomic medicine, and Global Vice President of Sales and Business Development at Plutora, a market leader in Continuous Delivery Management (CDM) for Enterprise IT.

Mark also served as the Global Vice President of Sales and Partnerships at SIGNIFYD, where they combined big data with machine learning to disrupt the e-commerce space. Before that, they were the Vice President of Sales and Business Development at Axcient, a leader in Recovery as a Service.

Mark Swendsen's earlier career includes roles such as Vice President of Sales at ShoreTel, where they managed service provider sales and led the company's European market expansion, and President at Ketchum Integration, where they oversaw day-to-day operations and sales and marketing efforts.

Throughout their career, Mark Swendsen has consistently demonstrated strong leadership and strategic skills, successfully driving business growth and achieving revenue targets.

Mark Swendsen attended Santa Clara University from 1992 to 1996, where they obtained a Bachelor of Arts degree in English. Mark later pursued further education at National University from 1997 to 2000, earning a Master's degree in Education. Additional information is not provided about Mark Swendsen's education after attending National University.